Delivery Order SPE2DB22D1002-SPE2DB25FLHD0
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Tasigna 150 mg capsules (28-count units) under a firm fixed-price contract valued at $12,015.80, with completion scheduled by September 9, 2025. This is a non-set-aside, competitively awarded delivery order issued against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $12,015.80 to AmerisourceBergen Drug Corp for Tasigna 150 mg capsules (quantity: 28 units) on September 4, 2025. This firm fixed-price, competitively awarded delivery order is scheduled for completion by September 25, 2025, with fulfillment occurring at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a non-set-aside procurement, indicating that AmerisourceBergen competed...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Tasigna 50 mg capsules in a quantity of 120 units. This is a firm fixed-price delivery order with a ceiling value of $11,638.02 and an ultimate completion date of September 23, 2025. The contract was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical...
- The Defense Logistics Agency awarded a $6,007.90 delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Tasigna 150 mg capsules (28-count packages). This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through open competition. The contract will be completed by September 2, 2025, with performance at AmerisourceBergen's Conshohocken, Pennsylvania facility. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Tasigna 150 mg capsules (28-count units) under a firm fixed price contract with a ceiling value of $6,007.90 and an ultimate completion date of September 24, 2025. This is a non-set-aside, competitively awarded delivery order issued as a child contract against AmerisourceBergen's existing Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a delivery order valued at $6,007.90 to AmerisourceBergen Drug Corp for Tasigna 150 mg capsules (28-count units) on July 23, 2025, with an ultimate completion date of August 13, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Tasigna is a specialized oncology medication used in the treatment of chronic myeloid leukemia, reflecting the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Tasigna 200 mg capsules (28-count packages) with a ceiling value of $6,007.90. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award through open competition. The order is scheduled for completion by September 9, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania location. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Tasigna 150 mg capsules (28-count) valued at $6,007.90 under a firm fixed-price contract type. The award, issued on August 7, 2025, with an ultimate completion date of August 28, 2025, represents a non-competitive delivery against AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The pharmaceutical product will be supplied to the place of performance in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,015.80 to AmerisourceBergen Drug Corp for the supply of Tasigna 150 mg capsules (28-count units) under a firm fixed price contract. The award was made on August 12, 2025, with an ultimate completion date of September 3, 2025, and does not utilize a set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $6,007.90 to AmerisourceBergen Drug Corp for Tasigna 150 mg capsules (28-count packaging) with a firm fixed price structure. This non-set-aside contract was awarded on July 30, 2025, with an ultimate completion date of August 20, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a single transaction under the company's...
- SPE2DB22D1002Indefinite Delivery Contract
- SPE2DB22D1002-SPE2DB25FLHD0Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Tasigna 150 mg capsules (28-count units) with a ceiling value of $6,007.90. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 24, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a non-set-aside procurement under the company's existing federal contract portfolio with the Defense Logistics Agency Medical Supply Chain. This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a $999.99 billion pharmaceutical prime vendor agreement extending through December 2026. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen Drug Corp supplies an extensive range of brand-name and generic medications, vaccines, and specialized medical commodities to support military and veteran healthcare systems globally. The Tasigna supply supports the Defense Health Agency and other government healthcare systems' pharmaceutical requirements for treatment of chronic myeloid leukemia, demonstrating the contractor's role in delivering specialized oncology medications through the DLA's comprehensive pharmaceutical support vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.0k | 9/3/25 |